Asuka Inoue

Prof. Dr. Asuka Inoue

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cell
Verified
Journal Article
Closed access
AIAsuka Inoue
Asuka Inoue
FRFrancesco Raimondi
Francesco Raimondi
FKFrancois Marie Ngako Kadji
Francois Marie Ngako Kadji
GSGurdeep Singh
Gurdeep Singh
TKTakayuki Kishi
Takayuki Kishi
RRRobert Bruce Russell
Robert Bruce Russell

18 March 2022 in eLife
Verified
Journal Article
Open access
AHAlexander S Hauser
Alexander S Hauser
CACharlotte Avet
Charlotte Avet
CNClaire Normand
Claire Normand
AMArturo Mancini
Arturo Mancini
AIAsuka Inoue
Asuka Inoue
DGDavid E Gloriam
David E Gloriam
Two-thirds of human hormones and one-third of clinical drugs act on membrane receptors that couple to G proteins to achieve appropriate functional responses. While G protein transducers from literature are annotated in the Guide to Pharmacology database, two recent large-scale datasets now expand the receptor-G protein ‘couplome’. However, these three datasets differ in scope and reported G protein couplings giving different coverage and conclusions on G protein-coupled receptor (GPCR)-G protein signaling. Here, we report a common coupling map uncovering novel couplings supported by both large-scale studies, the selectivity/promiscuity of GPCRs and G proteins, and how the co-coupling and co-expression of G proteins compare to the families from phylogenetic relationships. The coupling map and insights on GPCR-G protein selectivity will catalyze advances in receptor research and cellular signaling toward the exploitation of G protein signaling bias in design of safer drugs.

21 November 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
QQQianhui Qu
Qianhui Qu
WHWeijiao Huang
Weijiao Huang
DADeniz Aydin
Deniz Aydin
JPJoseph M. Paggi
Joseph M. Paggi
ASAlpay B. Seven
Alpay B. Seven
GSGeorgios Skiniotis
Georgios Skiniotis

10 November 2022 in Cell
Verified
Journal Article
Open access
JJJohn Janetzko
John Janetzko
RKRyoji Kise
Ryoji Kise
BBBenjamin Barsi-Rhyne
Benjamin Barsi-Rhyne
DSDirk H. Siepe
Dirk H. Siepe
FHFranziska M. Heydenreich
Franziska M. Heydenreich
BKBrian K. Kobilka
Brian K. Kobilka
Binding of arrestin to phosphorylated G protein-coupled receptors (GPCRs) is crucial for modulating signaling. Once internalized, some GPCRs remain complexed with β-arrestins, while others interact only transiently; this difference affects GPCR signaling and recycling. Cell-based and in vitro biophysical assays reveal the role of membrane phosphoinositides (PIPs) in β-arrestin recruitment and GPCR-β-arrestin complex dynamics. We find that GPCRs broadly stratify into two groups, one that requires PIP binding for β-arrestin recruitment and one that does not. Plasma membrane PIPs potentiate an active conformation of β-arrestin and stabilize GPCR-β-arrestin complexes by promoting a fully engaged state of the complex. As allosteric modulators of GPCR-β-arrestin complex dynamics, membrane PIPs allow for additional conformational diversity beyond that imposed by GPCR phosphorylation alone. For GPCRs that require membrane PIP binding for β-arrestin recruitment, this provides a mechanism for β-arrestin release upon translocation of the GPCR to endosomes, allowing for its rapid recycling.

25 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKouki Kawakami
Kouki Kawakami
MYMasataka Yanagawa
Masataka Yanagawa
SHSuzune Hiratsuka
Suzune Hiratsuka
MYMisaki Yoshida
Misaki Yoshida
YOYuki Ono
Yuki Ono
AIAsuka Inoue
Asuka Inoue
Signaling-biased ligands acting on G-protein-coupled receptors (GPCRs) differentially activate heterotrimeric G proteins and β-arrestins. Although a wealth of structural knowledge about signaling bias at the GPCR level exists (preferential engagement of a specific transducer), little is known about the bias at the transducer level (different functions mediated by a single transducer), partly due to a poor understanding of GPCR kinase (GRK)-mediated GPCR phosphorylation. Here, we reveal a unique role of the Gq heterotrimer as a determinant for GRK-subtype selectivity that regulates subsequent β-arrestin conformation and function. Using the angiotensin II (Ang II) type-1 receptor (AT1R), we show that β-arrestin recruitment depends on both GRK2/3 and GRK5/6 upon binding of Ang II, but solely on GRK5/6 upon binding of the β-arrestin-biased ligand TRV027. With pharmacological inhibition or genetic loss of Gq, GRK-subtype selectivity and β-arrestin functionality by Ang II is shifted to those of TRV027. Single-molecule imaging identifies relocation of AT1R and GRK5, but not GRK2, to an immobile phase under the Gq-inactive, AT1R-stimulated conditions. These findings uncover a previously unappreciated Gq-regulated mechanism that encodes GRK-subtype selectivity and imparts distinct phosphorylation-barcodes directing downstream β-arrestin functions.

21 January 2021 in Science
Verified
Journal Article
Closed access
PDF file
JSJeffrey S Smith
Jeffrey S Smith
TPThomas F. Pack
Thomas F. Pack
AIAsuka Inoue
Asuka Inoue
CLClaudia Lee
Claudia Lee
KZKevin Zheng
Kevin Zheng
SRSudarshan Rajagopal
Sudarshan Rajagopal
Another way for GPCRs to signal: G protein–coupled receptors (GPCRs) normally transmit signals by coupling to heterotrimeric guanine nucleotide–binding proteins (G proteins) or by binding β-arrestin proteins. Smith et al. provide evidence for another mechanism, an approximate combination of the two. They monitored the interaction of vasopressin type 2 receptors (V2Rs) and G α proteins in cultured cells using bioluminescent resonance energy transfer. Even though V2Rs do not signal canonically through G α i proteins, they promoted the formation of complexes containing β-arrestin and G α i , and this led to downstream signaling to extracellular signal-regulated kinase protein kinases. Science , this issue p. eaay1833